GT Biopharma, Inc. (GTBP) › Shares OutstandingGT Biopharma, Inc. (GTBP) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2010: 149.57M2011: 269.30M2012: 500.57M2013: 573.05M2014: 2.37M2015: 2.40M2016: 104.2K2017: 50.12M2018: 50.65M2019: 4.10M2020: 5.22M2021: 32.06M2022: 1.09M2023: 1.38M2024: 2.23M2025: 25.53M25.53M2010Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202525.53M+1042.8%20242.23M+61.8%20231.38M+26.6%20221.09M-96.6%202132.06M+514.4%20205.22M+27.1%20194.10M-91.9%201850.65M+1.1%201750.12M+47989.6%2016104.2K-95.7%20152.40M+1.4%20142.37M-99.6%2013573.05M+14.5%2012500.57M+85.9%2011269.30M+80.0%2010149.57M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share